SEARCH

SEARCH BY CITATION

Keywords:

  • Neisseria meningitidis;
  • carriage;
  • multiple carriage;
  • MLST;
  • clones;
  • populations

Abstract

  1. Top of page
  2. Abstract
  3. Methodological considerations
  4. Differentiation of carrier vs. patient strains
  5. Geographic structuring and temporal evolution of carrier populations in Europe
  6. Measurement of carriage of multiple lineages by individuals
  7. Establishment of the duration of carriage for given lineages
  8. Carriage and vaccination
  9. Conclusions
  10. Perspectives
  11. Acknowledgements
  12. References

Neisseria meningitidis, an obligate commensal of humans, normally colonizes the mucosa of the upper respiratory tract without affecting the host, a phenomenon known as carriage. In Europe, as much as 35% of young adults are carriers at a given time. Recent studies using molecular methods for clone identification have demonstrated the extensive genetic diversity of the strains isolated from carriers, in comparison with a limited number of hypervirulent strains associated with invasive disease. Published studies and new data generated through the framework of the EU-MenNet clearly indicated significant differences in pathogenicity between meningococcal clones and in the distribution of multilocus sequence types among isolates from asymptomatic carriers among European countries; simultaneous carriage of more than one meningococcal strain in the throat is rare, but occasionally occurs; and the commensal association of particular clones with a host is a long-term relationship, often lasting several months. Further investigations of the carrier state are warranted to improve our understanding of the epidemiology and pathogenesis of meningococcal disease, as well as to support the introduction and to measure the impact of mass vaccination.

Meningococcal disease is a life-threatening illness with annual incidence rates varying from 1 to 1000 per 100 000 in different parts of the world. The organism responsible for the disease, Neisseria meningitidis, is a strict human commensal which commonly colonizes the oropharyngeal mucosa of the man, its sole ecological niche, without causing any detectable symptoms. Asymptomatic carriage is an age-dependent phenomenon, with point prevalence carriage rates usually ranging from 10% to 35% in young adults (Cartwright et al., 1987; Caugant et al., 1994; Stephens, 1999; Claus et al., 2005). The majority of individuals will, at one time or another throughout life, harbour the bacterium asymptomatically in the throat. Thus, invasive disease is a very rare outcome of infection, usually occurring shortly after acquisition of the bacterium by a susceptible host (Edwards et al., 1977).

Causing disease is of no importance for the spread of meningococci and the population biology of N. meningitidis (Maiden, 2004); most patients with meningococcal disease have not been in contact with another case. The bacterium is transmitted between individuals when respiratory droplets from an infected – but symptom-less – person are spread to other individuals through close contact (deVoe, 1982). In closed and semi-closed populations, such as military recruits and university students, transmission increases and carriage rates may then reach close to 100% (Olcen et al., 1981; Caugant et al., 1992). Meningococci are particularly susceptible to drying; thus, transmission likely requires that the bacterium is protected by a polysaccharide capsule (Lipsitch & Moxon, 1997; Weber et al., 2006). Colonization of a new host necessitates, in addition, that the meningococci are piliated to permit adhesion to the epithelial cell surfaces (Stephens & McGee, 1981).

Studies performed in Europe have shown that carriage rates are very low in the first years of life, then sharply increase in teenagers and reach a peak in 20–24-year olds. Carriage rates decrease to less than 10% in older ages (Cartwright et al., 1987; Blackwell et al., 1990; Caugant et al., 1994; Claus et al., 2005).

In addition to age, a number of risk factors have been shown to be associated with meningococcal carriage (Cartwright, 1995; Krizova & Kriz, 1999). There are slightly more carriers in males than in females. Individuals with respiratory tract infections, of viral or bacterial origin, may be at high risk to become carriers (Stephens, 1999). Smoking, active as well as passive, is one of the strongest risk factors for becoming a meningococcal carrier (Stuart et al., 1989; Blackwell et al., 1992; Kremastinou et al., 1994). Low socio-economic status in some populations appears to increase the risk for carriage (Davies et al., 1996). These risk factors have been found to be independently associated with carriage in multivariate analyses, but in a number of recent studies it appears that the number and closeness of social contacts might be the most important elements (McLennan et al., 2006).

Exposure to meningococci through asymptomatic carriage has been shown to elicit an immune response. Mucosal immunity in carriers can be detected by increasing concentration of IgA in saliva (Robinson et al., 2002; Horton et al., 2005). Although not sufficient to prevent further colonization of the oropharynx, development of mucosal immunity may play an important role in prevention of the invasion of epithelial cells (Griffiss, 1995). Carriage of N. meningitidis also results in a humoral response, as demonstrated by increased serum bactericidal antibody activity (Jones et al., 1998; Kriz et al., 1999; Jordens et al., 2004; Raghunathan et al., 2006). Although the response is mainly strain-specific, some degree of cross-reactivity with heterologous strains is developed (Jordens et al., 2004).

Despite the importance of the carrier state in the biology of the meningococcus, the relationships between carriage and disease have not been fully elucidated. Noncarriers are considered a high-risk group for meningococcal disease as their capability to maintain a commensal relationship with an acquired strain is not known (Griffiss, 1995). On the other hand, development of serum bactericidal activity against a range of strains was demonstrated in a longitudinal study in individuals in whom no meningococcal carriage was detected (Jordens et al., 2004).

Most carrier studies are performed as cross-sectional analyses of a target population at a single point in time – snapshot studies. In those cases, a positive sample will not tell when the individual acquired the strain and a negative sample might simply result from low sensitivity of the swabbing method. A few studies have attempted to measure duration of meningococcal carriage by following subjects with repeated throat samples over time. These studies have shown that the meningococcal carrier state may be chronic, last for several months, be intermittent or transient (Kuzemenska et al., 1978; Broome, 1986). In most cases, strain characterization, to determine whether the same carried strain is kept, has either not been performed or the methods employed were relatively coarse. Duration of carriage may be dependent on the properties of the colonizing strain, not all meningococcal strains having the same propensity to establish a long-term commensal relationship with the host. This kind of investigation requires methods such as multilocus enzyme electrophoresis (MLEE) (Selander et al., 1986) or multilocus sequence typing (MLST) (Maiden et al., 1998) that can identify specific strains with a high degree of precision by assessing the diversity of randomly chosen, multiple genes encoding essential metabolic functions. With MLEE, genetic variation is assessed indirectly by examination of the gene products (normally metabolic enzymes) after starch gel electrophoresis and specific histochemical staining. With MLST, the DNA sequencing technology is used to measure the variation of genes directly and accurately. With both methods, genetic variants at multiple loci are combined into an allelic profile, designated as an electrophoretic type (ET) for MLEE or as sequence type (ST) for MLST.

Molecular characterization of the organisms colonizing the throat is essential to our understanding of the dynamics of transmission of N. meningitidis in the human population and, thus, the epidemiology of the disease. Because the meningococcus is both highly variable and naturally competent for transformation, it may readily change its genome by incorporating DNA from other meningococcal strains or from other closely related bacterial species, adapting to its environment, the human oropharyngeal mucosa. This phenomenon occurs during the carriage stage, when multiple strains of meningococci may colonize the same site or meningococci may share the same ecological niche with a variety of other commensal or pathogenic bacteria. Although it is well known that multiple strains of Streptococcus pneumoniae may be detected from a single nasopharyngeal sample (Brondson et al., 2004), attempts to determine such occurrences with N. meningitidis are basically nonexisting.

Much information regarding the meningococcal strains causing disease throughout the world has become available in the past two decades and this has been used to develop models for the population structure of the species (Maynard Smith et al., 1993). However, it is still very unclear to what extent meningococcal populations from healthy carriers are structured. For example, is the species thoroughly panmictic, if highly virulent strains are disregarded, or are some clones successful commensals? Are populations of carrier strains highly differentiated in function according to their geographic distribution or to characteristics of their host? To answer these questions and fully understand the epidemiology of meningococcal disease, the unequivocal genetic characterization of large collections of disease-associated and carried strains is indispensable.

Methodological considerations

  1. Top of page
  2. Abstract
  3. Methodological considerations
  4. Differentiation of carrier vs. patient strains
  5. Geographic structuring and temporal evolution of carrier populations in Europe
  6. Measurement of carriage of multiple lineages by individuals
  7. Establishment of the duration of carriage for given lineages
  8. Carriage and vaccination
  9. Conclusions
  10. Perspectives
  11. Acknowledgements
  12. References

Swabbing and cultivation

The swabbing technique and culture conditions are factors greatly influencing the detection of meningococcal carriage in healthy individuals. The site of sampling should include the posterior pharyngeal wall behind the uvula, and possibly the tonsils (Cartwright, 2001). Charcoal-impregnated swabs are recommended. The use of selective antibiotics, such as a combination of colimycin, lincomycin, amphotericin, and trimethoprim in media, is an excellent choice as it inhibits the growth of nonmeningococcal bacteria and thus significantly increases the yield of meningococci from the samples (Caugant et al., 1992).

Swabs may be directly plated onto solid medium on site or placed in an appropriate transport medium, for example Stuart medium, before plating later on in the laboratory. A comparison of these two methods using samples from high school students in the UK (Cunningham et al., 2001) showed a statistically significant higher carriage rate with direct plating (11.6% vs. 6.2%), whereas earlier investigations had not revealed such differences. In our hands, direct plating was not significantly better than the use of Stuart's transport media, at least when the plating in the laboratory was performed within 4 h of taking the samples (Table 1), but a somewhat lower carriage rate was obtained when the samples were kept in the transport medium for up to 24 h before plating (27.4% vs. 23.2%). Consequently, if plating can be performed within a few hours, the use of Stuart's medium is recommended as it clearly facilitates the manipulation, when performing a large carriage study.

Table 1.   Comparison of Stuart's transport medium for 4 or 24 h before plating and direct plating for identification of meningococcal carriers among 164 18–22-year-old military recruits, Norway 2003
MethodMeningococcal growthNo. of carriers (%)
  1. +Growth of meningococci;−, no growth of meningococci. In positive samples, the number of colonies is given in brackets if <20.

Direct plating+++(7)+(1)45 (27.4)
Stuart (4 h)+++ (1–2)46 (28.0)
Stuart (24 h)++ (1)38 (23.2)
Number of samples37631111648 (29.3)

Carriage studies may need to be performed at sites lacking personnel with sufficient microbiological experience for differential identification of meningococci in a complex sample as represented by the throat flora. After 24–48 h incubation of a sample on a selective plate, the whole bacterial growth may then be collected with a sterile loop, suspended in Greaves solution (Craven et al., 1978) and then frozen immediately at or below −20°C. Frozen samples can then be transported and taken up for analysis by trained personnel when convenient (Caugant et al., 2006). Meningococci have been recovered after 14 months from all the tested samples treated that way, even when as few as 10 meningococcal colonies were seen on the primary plate.

PCR-based methods for rapid discrimination of meningococcal clones within single throat samples

Alternative methods, including immunohistochemistry (Sim et al., 2000) and specific real-time PCR assays based on the porA gene (Jordens & Heckels, 2005), have been tested to detect meningococcal carriage and appear to be at least as sensitive as culture of throat swabs. PCR-based methods can also provide a mean of screening multiple colonies from single throat samples for genetic variants of N. meningitidis.

To study the genetic diversity of meningococcal colonies from a single throat sample, as part of new carriage studies in the course of the EU-MenNet project, we selected and subcultured usually up to 20 meningococcal colonies per plate after primary cultivation on selective media, for storage and further investigation. The genetic homogeneity of the colonies within each sample was screened by either randomly amplified polymorphic DNA (RAPD) analysis (Bart et al., 1998) using various primers (1281, 1254 and meningococcal USS) or by targeting DNA motifs with potential variable-number tandem repeats (VNTR) in the genome of N. meningitidis (Yazdankhah et al., 2005). Development of the VNTR method for meningococci showed that meningococcal patient isolates with similar MLST or MLEE types recovered from epidemiologically linked cases in a defined geographical area often presented similar VNTR patterns, whereas isolates of the same MLST or MLEE types without an obvious epidemiological link showed variable VNTR patterns (Yazdankhah et al., 2005). Thus, VNTR analysis appeared suitable for rapid differentiation between genetic variants within a throat sample.

Differentiation of carrier vs. patient strains

  1. Top of page
  2. Abstract
  3. Methodological considerations
  4. Differentiation of carrier vs. patient strains
  5. Geographic structuring and temporal evolution of carrier populations in Europe
  6. Measurement of carriage of multiple lineages by individuals
  7. Establishment of the duration of carriage for given lineages
  8. Carriage and vaccination
  9. Conclusions
  10. Perspectives
  11. Acknowledgements
  12. References

Phenotypic differences

The capsular polysaccharide is the outermost antigen on the meningococcal surface, a major virulence factor and the prime target for mucosal and humoral immunity. On the basis of antigenic variation of the capsule, N. meningitidis has been divided into 12 serogroups. Patient strains are encapsulated and five of these serogroups (A, B, C, W135, and Y) cause more than 90% of the invasive disease worldwide (Pollard, 2004). In contrast, c. 50% of the strains isolated from carriers lack capsule and are therefore serologically not serogroupable (Caugant et al., 1988; Ala'Aldeen et al., 2000). There are two essential reasons for the lack of capsule – the deletion of the capsule locus (the capsule nul or cnl meningococci) or down-regulation of the expression of the capsule either temporarily or permanently by one of a number of genetic mechanisms (Claus et al., 2002). Loss of capsule enhances the capability of meningococci to colonize the human nasopharynx and to avoid the human defence systems (Hammerschmidt et al., 1994), whereas capsulation is likely to be important to protect the bacterium during transmission, explaining why this property is preserved by the species and full commensalism not achieved (Lipsitch & Moxon, 1997).

To better understand the relationship between carrier and disease-causing strains, we performed a comparative study of the expressed capsular antigens in a collection of 667 meningococci isolated, within a 10-year period, from patients and carriers in three European countries, the Czech Republic, Greece, and Norway, representing the Eastern, Southern and Northern parts of Europe. Strains from all but one patient were serogroupable, whereas 30–45% of the carrier isolates were nonserogroupable (Fig. 1). Serogroup B strains predominated among both patient and carrier isolates: about 30% in each country among carriers, and 30–75% among patients. Although marked differences between countries were observed in the serogroup distribution of patient isolates, the serogroup distribution of the carrier isolates was similar between countries, with a predominance of serogroup B among isolates expressing a capsular polysaccharide, followed by serogroup Y. A highly significant association of serogroup B, C, and W135 capsule expression with disease was evidenced, with serogroup C estimated to be 14 times more strongly associated with disease than serogroup B; the association with disease was less strong for serogroup Y (Yazdankhah et al., 2004).

image

Figure 1.  Distribution of serogroups (%) among patient and carrier isolates of Neisseria meningitidis in three European countries, 1991–2000. White, Czech Republic; striped, Greece; black, Norway (adapted from Yazdankhah et al., 2004).

Download figure to PowerPoint

There is also some evidence that particular variants of the components of the meningococcal cell membrane are associated with invasive disease. PorA and PorB, the two major porins in N. meningitidis, are stable during chronic carriage (Jones et al., 1998), but isolates of the same clone within individual carriers may vary from being typable to nontypable using monoclonal antibodies, suggesting changes in the level of expression of the PorA and PorB antigens during carriage (Caugant et al., 1992). The lipooligosaccharide is another major virulence factor of N. meningitidis (Jones et al., 1992) inducing the production of pro-inflammatory mediators that may lead to septic shock (Brandtzæg & van Deuren, 2002). The lipooligosaccharide types identified in carrier strains differed from those expressed by patient isolates (Poolman et al., 1995).

Another structure that significantly differs between disease-causing strains and carrier strains is NadA, a novel surface protein involved in adhesion to host tissues. NadA had been demonstrated in c. 50% of the clinical isolates, especially in most of the so-called hypervirulent lineages, as defined by MLEE and MLST. However, most strains isolated from healthy people either lack the nadA gene or possess a quite distinct form of the gene (Commanducci et al., 2004).

Genotypic differences

When compared to collections of meningococci recovered from patients, the isolates obtained from the throat of healthy individuals are typically much more diverse. Whereas most of the cases of disease worldwide are caused by a limited number of hypervirulent lineages, which appear to have an increased propensity to cause invasive disease, carrier isolates are genetically extremely heterogeneous, with only a low proportion of carrier strains representing the hyperinvasive clones (Caugant, 1998; Jolley et al., 2000). This finding, originally based on analyses of N. meningitidis using MLEE, was generalized through the investigation of a large collection of isolates from patients and carriers in the Czech Republic, Greece, and Norway using the MLST method (Yazdankhah et al., 2004). The frequency distribution of clone complexes differed between disease and carrier isolate collections (Fig. 2). Whereas 20% of the disease isolates had STs that were not assigned to a known clonal complex, over one third of the carrier isolates fell into that ‘not assigned’ category. The association of clone-complexes with carriage or disease measured by the ratio of patient to carrier strains for the various lineages represented in the strain collection showed that the ST-11, ST-32 and ST-269 complexes were positively associated with disease, whereas the ST-23 and ST-35 complexes were positively associated with carriage (Table 2). When adjusted for year of isolation and geographical source, the associations of ST-11 with disease and of ST-23 with carriage were still highly significant (Yazdankhah et al., 2004). These data demonstrate that carrier populations are not panmictic and provide further evidence that important differences in pathogenicity exist between meningococcal clone complexes.

image

Figure 2.  Distribution of ST-complexes (%) among patient and carrier isolates of Neisseria meningitidis in three European countries, 1991–2000. White, Czech Republic; striped, Greece; black, Norway (adapted from Yazdankhah et al., 2004).

Download figure to PowerPoint

Table 2.   Association of the predominant clone-complexes with carriage and disease in Europe, 1991–2000 (adapted from Yazdankhah et al., 2004)
ST-complexNumber of patient isolatesNumber of carrier isolatesRatio
1193109.3
237320.2
3254183.0
356180.3
41/4444421.0
16216170.9
2691572.1
Other STs792090.4

Geographic structuring and temporal evolution of carrier populations in Europe

  1. Top of page
  2. Abstract
  3. Methodological considerations
  4. Differentiation of carrier vs. patient strains
  5. Geographic structuring and temporal evolution of carrier populations in Europe
  6. Measurement of carriage of multiple lineages by individuals
  7. Establishment of the duration of carriage for given lineages
  8. Carriage and vaccination
  9. Conclusions
  10. Perspectives
  11. Acknowledgements
  12. References

In the same way that clone-complexes of N. meningitidis recovered from disease cases are not uniformly distributed throughout the world, clone-complexes of N. meningitidis circulating in the asymptomatic population differ among countries. Members of the newly identified ST-162 complex, which has been associated with recent outbreaks in the Athens region (Tzanakaki et al., 2006), were present solely in the carrier isolate collection from Greece (Fig. 2). The clone-complex distributions were fairly similar in Norway and Greece. In contrast, the distribution in the Czech Republic was very divergent; the ST-23 and ST-269 complexes were absent but the ST-18 and ST-92 complexes well represented. Comparisons of the allele sequence frequencies for the seven housekeeping loci by analysis of molecular variance (Excoffier et al., 1992) demonstrated highly significant country-to-country differentiation. Although lower than that evidenced in comparing disease isolates, the genetic differentiation among countries of the carrier isolates was significant at all loci, with FST values ranging from 0.024 (abcZ locus) to 0.071 (aroE locus).

In an attempt to look at temporal changes in the meningococcal carrier population, we compared the clone-complex distribution in three collections of carrier isolates obtained over a 12-year period in Norway. Few changes over time were observed. This clonal stability of the carried population was in strong contrast to the variation in the frequency of the disease-causing clones over the same period. For example, the carriage rate of the ST-32 complex remained at around 5% for the whole time, but it was responsible for about 70% of the cases in 1991 and only 15% in 2003. Additionally, in that period the incidence of meningococcal disease decreased by a factor of 4. The reduction in disease rate, in spite of the stability of the prevalence of ST-32 among health carriers, may be the result of acquired immunity of the population toward that clone and/or alterations of the virulence properties of ST-32 strains over time. Therefore, it seems that, just as carriage rates cannot be used to predict changes in the epidemiology of meningococcal disease, carriage rates of hypervirulent clones cannot be directly related to disease incidence rates.

However, in a comparison of two carrier strain collections in the Czech Republic (81 strains in 1994–96 and 35 strains in 2002–2003), an increase in the representation of the ST-22, ST-32 and ST-41/44 complexes was seen over the 10-year period. This increase was associated with a decline of ST-92, a clone associated with carriage in the Czech Republic but rarely recovered elsewhere. It can be speculated that this temporal change in the carried meningococcal population in the Czech Republic may be a consequence of the increase in communication with Western and Southern Europe that has occurred since the early 1990s.

Measurement of carriage of multiple lineages by individuals

  1. Top of page
  2. Abstract
  3. Methodological considerations
  4. Differentiation of carrier vs. patient strains
  5. Geographic structuring and temporal evolution of carrier populations in Europe
  6. Measurement of carriage of multiple lineages by individuals
  7. Establishment of the duration of carriage for given lineages
  8. Carriage and vaccination
  9. Conclusions
  10. Perspectives
  11. Acknowledgements
  12. References

Recombination is the main force driving the evolution of the meningococcal genome (Feil et al., 1999; Jolley et al., 2005). Horizontal genetic exchange between strains of N. meningitidis must then occur during the carriage stage in the throat of healthy individuals colonized by multiple clones. In an attempt to provide evidence for multiple colonization and to determine the frequency of this occurrence, multiple colonies were isolated and characterized from throat samples of healthy carriers in the Czech Republic, Greece and Norway. Usually up to 20 meningococcal colonies per throat sample were picked and stored. The genetic homogeneity of the colonies in each sample was screened by RAPD or by the VNTR method. From each individual carrier, colonies with distinct RAPD or VNTR patterns were further characterized by serogrouping, serotyping, antibiotic susceptibility testing and MLST. Minor variation among colonies within a sample was more frequently detected using RAPD than the VNTR method. However, in several cases the RAPD variation was not confirmed by MLST analyses, showing that the minor variation obtained with RAPD reflected instability in experimental conditions rather than true genetic differences. Thus, as was also found in a study comparing RAPD and VNTR for analysis of outbreaks, VNTR proved more reliable than RAPD (Tzanakaki et al., 2006).

In the Czech Republic a carriage study was performed in 206 high school students between October 2002 and March 2003. Thirty three (16.0%) carriers were identified. A total of 1242 colonies from 119 positive samples were isolated and tested by RAPD. Twenty two RAPD patterns were distinguished. RAPD variation was detected among colonies in two samples from two different individuals. The presence of distinct clones was confirmed by MLST (ST-254 and ST-255 in one sample and ST-53 and ST-110 in the other one) (Krizova et al., 2004; Table 3). The genetic relationships among the STs of the carrier isolates in the Czech Republic are shown in Fig. 3.

Table 3.   STs (number of colonies) of Neisseria meningitidis colonizing individual carriers at a single swabbing
CarrierSample 1Sample 2Sample 3Sample 4Sample 5Sample 6
  1. NS, not sampled.

CR131ST-53 (20)ST-53 (9)ST-110 (11)NSST-110 (16)ST-110 (6)
 ST-110 (1)    
CR200ST-254 (8)ST-254 (20)NSNSST-254 (47)NS
ST-255 (2)     
N4132ST-23 (20)ST-23 (19)NSST-23 (3)NSST-32 (20)
 ST-32 (1) ST-32 (1)  
N4365ST-2328 (20)ST-275 (20)ST-275 (20)ST-275 (19)NSST-275 (20)
   ST-2328 (1)  
image

Figure 3.  Genetic relationships among STs of carrier isolates recovered from schoolchildren, Czech Republic, 2003. The tree was constructed with the neighbour-joining method using the program provided at http://pubmlst.org/software/analysis. Isolates of the carrier no. 131 are marked by an asterisk; isolates of the carrier no. 200 are marked by two asterisks.

Download figure to PowerPoint

In Norway a carriage study in 126 military recruits was performed between February and July 2003. A total of 78 carriers (carriage rate =61.9%) were identified. In all, 5902 individual colonies were isolated and preserved. Nineteen of the 78 carriers were selected for studying multiple carriage; 1897 colonies from 104 positive samples were tested by VNTR. Several VNTR types were seen in some throat samples. The presence of more than one clone, as confirmed by MLST, was detected in only three samples from two carriers (ST-23 and ST-32 in two samples for the same individual and ST-275 and ST-2328 in one sample from another carrier).

In Greece two carriage studies were performed in university students aged 18–25 years old, between February and June 2002 (n=102) and between February and June 2003 (n=100), respectively. Overall, 37 (18%) carriers were identified. About 2000 colonies were isolated from 124 throat samples and tested by RAPD and phenotypic methods (serogroup, serotype/subtype). Minor changes in one of the two primers used were detected within individual samples of three carriers. However, none of these samples harboured more than one clone, as evidenced by MLST.

Overall, about 15 colonies per sample were examined in nearly 350 samples. In five (1.4%) of the samples, more than one clone was detected. In picking 15 colonies, the probability of detecting carriage of more than one clone is about 80% even if the proportion of the less common clone is <10% of the colonies. Although rare, colonization of the throat by multiple meningococcal clones was clearly demonstrated. In one individual, colonization of the throat by the same two clones was observed in two samples, 2 months apart, suggesting that the phenomenon can be stable. Meningococcal carriage is a common phenomenon and thousands of genotypes exist. It is thus surprising that in most cases the meningococcal flora is dominated by a single clone. Clonal exclusion may be a consequence of differential production of bacteriocins by various strains, resulting in killing of the susceptible nonproducers. However, bacteriocin production is a very rare property of meningococcal strains (Allunans & Bøvre, 1996). Clonal exclusion may more likely reflect differences in fitness of the colonizing strains, as for example differences in multiplication rate or in resistance to the host defences (Lipsitch & Moxon, 1997). While colonization of healthy individuals by multiple clones in relatively similar abundance is a rare event, it is likely very significant to the biology of N. meningitidis and is one of the main reasons for the difficulties in designing an effective universal vaccine against meningococcal disease.

Establishment of the duration of carriage for given lineages

  1. Top of page
  2. Abstract
  3. Methodological considerations
  4. Differentiation of carrier vs. patient strains
  5. Geographic structuring and temporal evolution of carrier populations in Europe
  6. Measurement of carriage of multiple lineages by individuals
  7. Establishment of the duration of carriage for given lineages
  8. Carriage and vaccination
  9. Conclusions
  10. Perspectives
  11. Acknowledgements
  12. References

Knowledge regarding the duration of carriage is limited because most longitudinal studies of carriage have used only phenotypic techniques for strain characterization and many carried isolates are both nonserogroupable and nonserotypable. Another difficulty is motivation of the volunteers to repeatedly have a throat sample taken, which, although not dangerous, is not especially pleasant.

Longitudinal studies were performed at monthly intervals over 5 or 6 months. In total, 534 individuals aged 15–25 years old were enrolled in three study sites (Czech Republic, Greece and Norway). Carriage rates fluctuated between 16% and 62% depending on the study site and the population sampled, but the carriage rate showed little variation at each site during the survey. Stable carriers were defined as individuals from whom at least four throat samples had been taken, all of them were positive for meningococci. Overall, 43–69% of the individuals were found to be stable carriers.

Using RAPD or VNTR in combination with phenotypic methods to screen strain heterogeneity, and verification using MLST, the dynamic of meningococcal carriage in the 147 individual hosts was followed. For only one of the schoolchildren (CR-131) was a change of strain evidenced in the course of the study period, whereas eight (10%) of the 77 military recruits experienced at least one strain replacement (Table 4). In several cases, the change of clone was temporary, suggesting that the individuals either were recolonized by the previous colonizing clone from their environment or may be harbouring several different meningococcal clones within a sample, the apparent clone replacement simply being a consequence of the colony picked and analyzed.

Table 4.   Characteristics (ST-complex; serogroup:serotype:serosubtype) of the meningococcal strains in nine healthy carriers experiencing clonal replacement over a 6-month period
Carrier no.Sample 1Sample 2Sample 3Sample 4Sample 5Sample 6
  1. NS, not sampled; NG, nonserogroupable; NT, nonserotypable; NST, nonserosubtypable; UA, unassigned.

CR131535341/44NS41/4441/44
NG:21:P1.7NG:21:P1.7B:4:P1.15 B:4:P1.15B:4:P1.15
N41322332NS32NS32
Y:14:P1.6NG:15:P1.7 NG:15:P1.7 NG:15:P1.7
N4331UA198UANS198NS
29E:16:P1.1629E:NT:NST29E:16:P1.16 NG:NT:P1.6 
N4358UAUAUAUA2323
NG:4,7:P1.7,1NG:4,7:P1.7,1NG:4,7:P1.7,1NG:4,7:P1.7,1Y:14,19:P1.5,2Y:14,19:P1.5,2
N436523269269269NS269
Y:14,19:P1.6B:7:P1.9B:7:P1.9B:7:P1.9 B:7:P1.9
N5013269269UA269269269
C:NT:P1.7,1C:NT:P1.7,1NG:16:P1.2C:NT:P1.7,1C:NT:P1.7C:NT:P1.7
N5032UA198269NS198UA
NG:16:P1.5,2NG:15:P1.6C:NT:P1.1 NG:15:P1.6NG:16:P1.5,2
N5036323232NSNSUA
NG:15:NSTNG:15:NSTNG:15:NST  NG:7:P1.12,13
N803841/4441/44NSNS26941/44
NG:14,19:P1.7NG:14,19:P1.7  B:7:P1.9NG:14,19:P1.7

These studies demonstrated that the commensal association of particular clones with a host is a long-term relationship, with 90% of the carriers keeping the same clone for at least 5–6 months. Whether some clones are better at establishing a long-term commensal relationship than others still remains to be demonstrated. Despite the rather large size of this study, because of the genetic diversity of the carried meningococcal population the number of carriers of each clone or even of each clone-complex was too limited for analysis. The ST-23 complex seems to be a very good colonizer and readily transmitting among associated individuals. In contrast, as seen in other studies (Caugant et al., 1988; Claus et al., 2005), the ST-11 complex strains (formerly ET-37 complex) were seldom found in healthy carriers; they were absent in the longitudinal studies in Greece and in the Czech Republic, and the two military recruits identified with an ST-11 lost the carriage status in the following samples. These data suggest that strains of the ST-11 complex must have a high transmission rate to balance their short duration of carriage (Moxon & Jansen, 2005). The strong association between the ST-11 complex and expression of a serogroup C capsule (Yazdankhah et al., 2004; Claus et al., 2005) may ensure the fitness of the clonal complex in terms of transmission, as well as its pathogenic behaviour, while counteracting its capability to be carried for a long time.

Carriage and vaccination

  1. Top of page
  2. Abstract
  3. Methodological considerations
  4. Differentiation of carrier vs. patient strains
  5. Geographic structuring and temporal evolution of carrier populations in Europe
  6. Measurement of carriage of multiple lineages by individuals
  7. Establishment of the duration of carriage for given lineages
  8. Carriage and vaccination
  9. Conclusions
  10. Perspectives
  11. Acknowledgements
  12. References

A number of studies have been performed to investigate the effect of vaccination on meningococcal carriage, using the polysaccharide vaccines, the polysaccharide conjugate vaccines, and, to a lesser extent, the serogroup B outer membrane vesicle vaccine.

The effect of the polysaccharide vaccines on colonization of the meningococci is, at best, transient, because the level of antibodies declines rapidly to near prevaccination levels and is insufficient to prevent colonization on the mucosa (Jodar et al., 2002). With outer membrane vesicle vaccines against serogroup B disease, a slight reduction in carriage rate among vaccinated individuals has been seen (Rosenqvist et al., 1994). When conjugated to protein antigens, however, polysaccharide vaccines may induce an immune response that is higher than that achieved by the polysaccharide vaccines (Zhang et al., 2000), and leak of antibodies to the mucosa then affects colonization.

An effect on nasopharyngeal carriage was shown by Maiden and colleagues, who demonstrated a 67% reduction from 0.45% to 0.15% in the prevalence of serogroup C carriage in adolescents 1 year after the introduction of the C conjugate polysaccharide vaccine in the UK (Maiden & Stuart, 2002). Reduction of carriage was found to result in a similar reduction in the incidence of meningococcal disease in nonvaccinated groups and contributes to herd immunity (Ramsay et al., 2005). Thus, when introducing new meningococcal vaccines and assessing their effectiveness, it is essential to consider their effect on the dynamics of meningococcal carriage.

Conclusions

  1. Top of page
  2. Abstract
  3. Methodological considerations
  4. Differentiation of carrier vs. patient strains
  5. Geographic structuring and temporal evolution of carrier populations in Europe
  6. Measurement of carriage of multiple lineages by individuals
  7. Establishment of the duration of carriage for given lineages
  8. Carriage and vaccination
  9. Conclusions
  10. Perspectives
  11. Acknowledgements
  12. References

Carriage studies are important to improve our understanding of the population structure of N. meningitidis and the epidemiology of meningococcal disease. MLST analyses have confirmed the extensive diversity of the carried meningococci, but have also provided evidence that meningococcal populations from healthy carriers comprise a number of successful clones that are geographically widespread. In most cases, the commensal association with a meningococcal strain is a long-term relationship (at least 5–6 months) and clone replacement occurs during long-term carriage, albeit infrequently. Although rare in our experimental conditions, simultaneous colonization by multiple clones was demonstrated, indicating that recombination between them may generate novel genotypes that can be selected within the human host.

Furthermore, it was confirmed that hypervirulent ST-complexes are rare among strains from carriers. Variation in incidence of disease caused by these clonal complexes does not appear to reflect a variation in their carriage rate in the human population. The hypervirulent clones vary greatly in their capability to establish a commensal relationship with their host, the strains of the ST-11 complex being especially poor colonizers. In contrast, some clones, such as the ST-23 complex, appear to be well-adapted to the commensal relationship with the host.

Perspectives

  1. Top of page
  2. Abstract
  3. Methodological considerations
  4. Differentiation of carrier vs. patient strains
  5. Geographic structuring and temporal evolution of carrier populations in Europe
  6. Measurement of carriage of multiple lineages by individuals
  7. Establishment of the duration of carriage for given lineages
  8. Carriage and vaccination
  9. Conclusions
  10. Perspectives
  11. Acknowledgements
  12. References

Further investigations of the following aspects of meningococcal carriage are warranted:

  • 1
    As most carriers were stable carriers for a period of 5–6 months, it is clear that to determine the duration of carriage and how it varies for specific clones it will be necessary to follow many individuals for much longer periods.
  • 2
    There is a need for a better assessment of the relation between carried and disease-causing clones and for accurate determination of the relative virulence potential of hypervirulent sequence types and clonal complexes, especially as additional ones are identified.
  • 3
    The geographical component of the diversity of carriage strains should be ascertained further. This might be especially important in relation to the introduction of new meningococcal vaccines and estimation of the herd effect.
  • 4
    Additional carriage studies, including extensive molecular strain characterization, should be performed before and after vaccination in countries where mass vaccination is introduced.
  • 5
    The effect of vaccination in individual carriers should be studied and coupled to serological analyses.

Acknowledgements

  1. Top of page
  2. Abstract
  3. Methodological considerations
  4. Differentiation of carrier vs. patient strains
  5. Geographic structuring and temporal evolution of carrier populations in Europe
  6. Measurement of carriage of multiple lineages by individuals
  7. Establishment of the duration of carriage for given lineages
  8. Carriage and vaccination
  9. Conclusions
  10. Perspectives
  11. Acknowledgements
  12. References

Carrier studies are demanding investigations and we are very grateful to many colleagues for their support and participation. In particular, we want to thank Jitka Kalmusova, Konstantinos Kesanopoulos, Martin Musilek and Siamak Yazdankhah for their contribution to the large studies on multiple carriage and carriage duration.

Financial support was provided by the EU-MenNet project of the European Commission Contract QLK2-CZ-2001-01436. This work made use of the Multi Locus Sequence Typing website (http://pubmlst.org/neisseria/) sited at the University of Oxford and funded by the Wellcome Trust and European Union.

References

  1. Top of page
  2. Abstract
  3. Methodological considerations
  4. Differentiation of carrier vs. patient strains
  5. Geographic structuring and temporal evolution of carrier populations in Europe
  6. Measurement of carriage of multiple lineages by individuals
  7. Establishment of the duration of carriage for given lineages
  8. Carriage and vaccination
  9. Conclusions
  10. Perspectives
  11. Acknowledgements
  12. References
  • Ala'Aldeen DA, Neal KR, Ait-Tahar K, Nguyen-Van-Tam JS, English A, Falla TJ, Hawkey PM & Slack RC (2000) Dynamics of meningococcal long-term carriage among university students and their implications for mass vaccination. J Clin Microbiol 38: 23112316.
  • Allunans J & Bøvre K (1996) Bacteriocins in Neisseria meningitidis. Screening of systemic patient strains and pharyngeal isolates from healthy carriers. APMIS 104: 206212.
  • Bart A, Schuurman IG, Achtman M, Caugant DA, Dankert J & Van Der Ende A (1998) Randomly amplified polymorphic DANN genotyping of serogroup A meningococci yields results similar to those obtained by multilocus enzyme electrophoresis and reveals new genotypes. J Clin Microbiol 36: 17461749.
  • Blackwell CC, Weir DM, James VS, Todd VT, Banatvala N, Chaudhuri AK, Gray HG, Thomson EJ & Fallon RJ (1990) Secretor status, smoking and carriage of Neisseria meningitidis. Epidemiol Infect 104: 203209.
  • Blackwell CC, Tzanakaki G, Kremastinou J, Weir DM, Vakalis N, Elton RA, Mentis A & Fatouros N (1992) Factors affecting carriage of Neisseria meningitidis among Greek military recruits. Epidemiol Infect 108: 441448.
  • Brandtzæg P & Van Deuren M (2002) Current concepts in the role of the host response in Neisseria meningitidis septic shock. Curr Opin Infect Dis 15: 247252.
  • Broome CV (1986) The carrier state: Neisseria meningitidis. J Antimicrob Chemother 18 (Suppl. A): 2534.
  • Brondson MA, O'Brien KL, Facklam RR, Whitney CG, Schwartz B & Carlone GM (2004) Immunoblot method to detect Streptococcus pneumoniae and identify multiple serotypes from nasopharyngeal secretions. J Clin Microbiol 42: 15961600.
  • Cartwright K (1995) Meningococcal carriage and disease. Meningococcal Disease (CartwrightK, ed), pp. 115146. John Wiley & Sons, Ltd, Chichester, UK.
  • Cartwright K (2001) Epidemiology, surveillance, and population biology: carriage studies. Meningococcal Disease – Methods and Protocols (PollardAJ & MaidenMCJ, eds), pp. 293311. Humana Press Inc, Totowa, NJ.
  • Cartwright KA, Stuart JM, Jones DM & Noah ND (1987) The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica. Epidemiol Infect 99: 591601.
  • Caugant DA (1998) Population genetics and molecular epidemiology of Neisseria meningitidis. APMIS 106: 505525.
  • Caugant DA, Kristiansen B-E, Frøholm LO, Bøvre K & Selander RK (1988) Clonal diversity of Neisseria meningitidis from a population of asymptomatic carriers. Infect Immun 56: 20602068.
  • Caugant DA, Høiby EA, Rosenqvist E, Frøholm LO & Selander RK (1992) Transmission of Neisseria meningitidis among asymptomatic military recruits and antibody analysis. Epidemiol Infect 109: 241253.
  • Caugant DA, Høiby EA, Magnus P, Scheel O, Hoel T, Bjune G, Wedege E, Eng J & Frøholm LO (1994) Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population. J Clin Microbiol 32: 323330.
  • Caugant DA, Fogg C, Bajunirwe F et al. (2006) Pharyngeal carriage of Neisseria meningitidis in 2–19-year-old individuals in Uganda. Trans Roy Soc Trop Med Hyg 100: 11591163.
  • Claus H, Maiden MC, Maag R, Frosch M & Vogel U (2002) Many carried meningococci lack the genes required for capsule synthesis and transport. Microbiology 148: 18131819.
  • Claus H, Maiden MC, Wilson DJ, McCarthy ND, Jolley KA, Urwin R, Hessler F, Frosch M & Vogel U (2005) Genetic analysis of meningococci carried by children and young adults. J Infect Dis 191: 12631271.
  • Commanducci M, Bambini S, Caugant DA, Mora M, Brunelli B, Capecchi B, Ciucchi L, Rappuoli R & Pizza M (2004) NadA diversity and carriage in Neisseria meningitidis. Infect Immun 72: 42174223.
  • Craven DE, Frasch CE, Robbins JB & Feldman HA (1978) Serogroup identification of Neisseria meningitidis: comparison of an antiserum agar method with bacterial slide agglutination. J Clin Microbiol 7: 410414.
  • Cunningham R, Matthews R, Lewendon G, Harrison S & Stuart JM (2001) Improved rate of isolation of Neisseria meningitidis by direct plating of pharyngeal swabs. J Clin Microbiol 39: 45754576.
  • Davies AL, O'Flanagan D, Salmon RL & Coleman TJ (1996) Risk factors for Neisseria meningitidis carriage in a school during a community outbreak of meningococcal infection. Epidemiol Infect 117: 259266.
  • DeVoe IW (1982) The meningococcus and mechanisms of pathogenicity. Microbiol Rev 46: 162190.
  • Edwards EA, Devine LF, Sengbusch GH & Ward HW (1977) Immunological investigations of meningococcal disease. III. Brevity of group C acquisition prior to disease occurrence. Scand J Infect Dis 9: 105110.
  • Excoffier L, Smouse PE & Quattro JM (1992) Analysis of molecular variance inferred from metric distances among DNA haplotypes: application to human mitochondrial DNA restriction data. Genetics 131: 479491.
  • Feil EJ, Maiden MC, Achtman M & Spratt BG (1999) The relative contributions of recombination and mutation to the divergence of clones of Neisseria meningitidis. Mol Biol Evol 16: 14961502.
  • Griffiss JM (1995) Mechanism of host immunity. Meningococcal Disease (CartwrightK, ed), pp. 3670. John Wiley & Sons, Ltd, Chichester, UK.
  • Hammerschmidt S, Birkholz C, Zahringer U, Robertson DB, Van Putten J, Ebeling O & Frosch M (1994) Contribution of genes from the capsule gene complex (cps) to lipooligosaccharide biosynthesis and serum resistance in Neisseria meningitidis. Mol Microbiol 11: 885896.
  • Horton RE, Stuart J, Christensen H, Borrow R, Guthrie T, Davenport V & Finn AThe ALSPAC Study Team.Williams NA & Heyderman RS (2005) Influence of age and carriage status on salivary IgA to Neisseria meningitidis. Epidemiol Infect 133: 883889.
  • Jodar L, Feavers IM, Salisbury D & Granoff DM (2002) Development of vaccines against meningococcal disease. The Lancet 27: 14991508.
  • Jolley KA, Kalmusova J, Feil EJ, Gupta S, Musilek M, Kriz P & Maiden MC (2000) Carried meningococci in the Czech Republic: a diverse recombining population. J Clin Microbiol 38: 44924498.
  • Jolley KA, Wilson DJ, Kriz P, McVean G & Maiden MC (2005) The influence of mutation, recombination, population history, and selection on patterns of genetic diversity in Neisseria meningitidis. Mol Biol Evol 22: 562569.
  • Jones DM, Borrow R, Fox AJ, Gray S, Cartwright KA & Poolman JT (1992) The lipooligosaccharide immunotype as a virulence determinant in Neisseria meningitidis. Microb Pathog 13: 219224.
  • Jones GR, Christodoulides M, Brooks JL, Miller AR, Cartwright KA & Heckels JE (1998) Dynamics of carriage of Neisseria meningitidis in a group of military recruits: subtype stability and specificity of the immune response following colonization. J Infect Dis 178: 451459.
  • Jordens JZ & Heckels JE (2005) A novel porA-based real-time PCR for detection of meningococcal carriage. J Med Microbiol 54: 463466.
  • Jordens JZ, Williams JN, Jones GR & Heckels JE (2002) Detection of meningococcal carriage by culture and PCR of throat swabs and mouth gargles. J Clin Microbiol 40: 7579.
  • Jordens JZ, Williams JN, Jones GR, Christodoulides M & Heckels JE (2004) Development of immunity to serogroup B meningococci during carriage of Neisseria meningitidis in a cohort of university students. Infect Immun 72: 65036510.
  • Kremastinou J, Blackwell CC, Tzanakaki G, Kallergi C, Elton R & Weir DM (1994) Parental smoking and carriage of Neisseria meningitidis among Greek schoolchildren. Scand J Infect Dis 26: 719723.
  • Kriz P, Kriz B, Svandova E & Musilek M (1999) Antimeningococcal herd immunity in the Czech Republic – influence of an emerging clone. Neisseria meningitidis ET-15/37. Epidemiol Infect 123: 193200.
  • Krizova P & Kriz B (1999) Factors influencing the genesis and development of invasive meningococcal disease and carriership of Neisseria meningitidis– results of nationwide prospective questionnaire survey of cases and controls [in Czech]. Epidemiol Mikrobiol Imunol 48: 140152.
  • Krizova P, Kalmusova J, Musilek M, Felsberg J, Haugvicova R & Vlckova J (2004) A study of long-term duration and multiple carriage of Neisseria meningitidis in healthy population by molecular biology methods, [in Czech]. Epidemiol Mikrobiol Imunol 53: 2536.
  • Kuzemenska P, Burian V & Hausenblasova M (1978) Circulation of N. meningitidis in a child community. J Hyg Epid Microb Immunol 22: 90107.
  • Lipsitch M & Moxon ER (1997) Virulence and transmissibility of pathogens: what is the relationship? Trends Microbiol 5: 3137.
  • Maiden MC & Stuart JM (2002) Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination. The Lancet 359: 18291831.
  • Maiden MC, Bygraves JA, Feil E et al. (1998) Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci USA 95: 31403145.
  • Maiden MCJ (2004) Dynamics of bacterial carriage and disease: lessons from the meningococcus. Hot Topics in Infection and Immunity in Children (PollardAJ, McCrackenGHJr & FinnA, eds), pp. 2329. Kluwer Academic/Plenum Publishers, New York.
  • Maynard Smith J, Smith NH, O'Rourke M & Spratt BG (1993) How clonal are bacteria? Proc Natl Acad Sci USA 90: 43844388.
  • McLennan J, Kafatos G, Neal K et al. (2006) Social behaviour and meningococcal carriage in British teenagers. Emerg Infect Dis 12: 950957.
  • Moxon ER & Jansen VAA (2005) Phage variation: understanding the behaviour of an accidental pathogen. Trends Microbiob 13: 563565.
  • Olcen P, Kjellander J, Danielsson D & Lindquist BL (1981) Epidemiology of Neisseria meningitidis; prevalence and symptoms from the upper respiratory tract in family members to patients with meningococcal disease. Scand J Infect Dis 13: 105109.
  • Pollard AJ (2004) Global epidemiology of meningococcal disease and vaccine efficacy. Pedriatr Infect Dis J 23: S274S279.
  • Poolman JT, Van Der Ley PA & Tommassen J (1995) Surface Structure and secreted products of meningococci. Meningococcal Disease (CartwrightK, ed), pp. 2134. John Wiley & Sons, Ltd, Chichester, UK.
  • Raghunathan PL, Jones JD, Tiendrebeogo SR et al. (2006) Predictors of immunity after a major serogroup W-135 meningococcal disease epidemic, Burkina Faso, 2002. J Infect Dis 193: 607616.
  • Ramsay ME, Andrews NJ, Trotter CL, Kaczmarski EB & Miller E (2005) Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis. BMJ 326: 365366.
  • Robinson K, Neal KR, Howard C et al. (2002) Characterization of humoral and cellular immune responses elicited by meningococcal carriage. Infect Immun 70: 13011309.
  • Rosenqvist E, Bjune G, Feiring B, Eng J, Frøholm LO, Høiby A, Moe B & Nøkleby H (1994) Changes in carrier status of Neisseria meningitidis in teenagers during a group B outer membrane vaccination trial in Norway. Pathobiology and Immunobiology of Neisseriaceae. Eighth International Pathogenic Neisseria Conference (Conde-GlezCJ, MorseS, RiceP, SparlingF & CalderonE, eds), pp. 895901. Instituto National de Salud Publica, Morelos, Mexico.
  • Sim RJ, Harrison MM, Moxon ER & Tang CM (2000) Underestimation of meningococci in tonsillar tissue by nasopharyngeal swabbing. The Lancet 356: 16531654.
  • Selander RK, Caugant DA, Ochman H, Musser JM, Gilmour MN & Whittam TS (1986) Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics. Appl Environ Microbiol 51: 873884.
  • Stephens DS (1999) Uncloaking the meningococcus: dynamics of carriage and disease. The Lancet 353: 941942.
  • Stephens DS & McGee ZA (1981) Attachement of Neisseria meningitidis to human mucosal surfaces: influence of pili and type of receptor cell. J Infect Dis 143: 525532.
  • Stuart JM, Cartwright KA, Robinson PM & Noah ND (1989) Effect of smoking on meningococcal carriage. The Lancet 2: 723725.
  • Tzanakaki G, Kesanopoulos K, Yazdankhah S, Levidiotou S, Kremastinou J & Caugant DA (2006) Conventional and molecular investigation of meningococcal isolates in relation to two outbreaks in the area of Athens, Greece. Clin Microbiol Infect 12: 10241026.
  • Weber MV, Claus H, Maiden MC, Frosch M & Vogel U (2006) Genetic mechanisms for loss of encapsulation in polysialyltransferase-gene-positive meningococci isolated from healthy carriers. Int J med Microbiol 296: 475484.
  • Yazdankhah S, Kriz P, Tzanakaki G, Kremastinou Kalmusova J, Musilek M, Alvestad T, Jolley K, Caugant DA & Maiden MC (2004) Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece and Norway. J Clin Microbiol 42: 51465153.
  • Yazdankhah SP, Lindstedt B-A & Caugant DA (2005) Use of variable-number tandem repeats to examine genetic diversity of Neisseria meningitidis. J Clin Microbiol 43: 16991705.
  • Zhang Q, Choo S, Everard J, Jennings R & Finn A (2000) Mucosal immune responses to meningococcal group C conjugate and group A and C polysaccharide vaccines in adolescents. Infect Immun 68: 26922697.